Now that a third COVID-19 vaccine has been given emergency-use authorization, Michelle Mello and colleagues ask whether individuals should be able to choose which vaccine they receive.
Although health care billing claims data have been widely used to study health care use, spending, and policy changes, their use in the study of infectious disease has been limited.
Paul H. WiseSenior FellowProfessor, Pediatrics, Senior Fellow, FSI
Matthew KohrmanSenior Fellow, by courtesyAssociate Professor, Anthropology
Lanhee J. ChenAffiliate, CDDRLDavid and Diane Steffy Fellow in American Public Policy Studies, Hoover Institution, Director of Domestic Policy Studies and Lecturer, Public Policy Program
Mintu TurakhiaAssociate Professor, MedicineAffiliated Faculty